SCHEMBL17859571

SCHEMBL17859571

C[N+]1(C)CCN(CCCOCCN2CCOc3cc(N)ccc32)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.39
SLC6A4 P31645 1/20 0.39
KCNH2 Q12809 2/20 0.36
REN P00797 1/20 0.35
NOS3 P29474 4/20 0.34
NOS1 P29475 4/20 0.34
NOS2 P35228 3/20 0.34
CHRM2 P08172 2/20 0.32
CHRM1 P11229 2/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM3 P20309 1/20 0.32
NPY5R Q15761 2/20 0.31
HRH3 Q9Y5N1 3/20 0.31
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
HTR2A P28223 1/20 0.30
MAPK1 P28482 1/20 0.30
SCN1A P35498 1/20 0.30
HTR2B P41595 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17859578 0.96 HTR1A (0.38) HTR1ASLC6A4KCNH2RENNOS3
SCHEMBL17859567 0.91 NOS3 (0.37) HTR1ASLC6A4KCNH2RENNOS3
SCHEMBL17859576 0.90 HTR1A (0.44) HTR1ASLC6A4KCNH2RENNOS3
SCHEMBL17859573 0.88 NOS3 (0.42) HTR1ASLC6A4KCNH2RENNOS3
SCHEMBL17859569 0.87 NOS3 (0.38) HTR1ASLC6A4KCNH2NOS3NOS1
SCHEMBL17859565 0.84 NOS3 (0.40) HTR1ASLC6A4KCNH2NOS3NOS1
SCHEMBL19602140 0.83 HTR1A (0.33) HTR1ASLC6A4KCNH2RENNOS3
SCHEMBL17859568 0.83 NOS3 (0.41) HTR1ASLC6A4KCNH2NOS3NOS1
SCHEMBL17859628 0.82 NOS3 (0.44) HTR1ASLC6A4KCNH2NOS3NOS1
SCHEMBL17859579 0.82 NOS3 (0.33) HTR1ASLC6A4KCNH2RENNOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170327690-A1 CATIONIC BENZOXAZINE DERIVATIVES AND USE IN HAIR DYEING OREAL (FR) 2017-11-16 US disclosed
WO-2016097023-A1 CATIONIC BENZOXAZINE DERIVATIVES AND USE IN HAIR DYEING L'OREAL (FR) 2016-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327690-A1 CATIONIC BENZOXAZINE DERIVATIVES AND USE IN HAIR DYEING TYR, CAT, CYC1 HTR1A 213/4885SLC6A4 443/4885KCNH2 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.